Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors.

Vincent Avecilla, Mayur Doke, Sandeep Appunni, Muni Rubens, Venkataraghavan Ramamoorthy, Jayanta Kumar Das

Abstract readReview

In one paragraph

Review in Medical sciences (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Chronic ACL Injury Drives a Fibrotic and Matrix-Degradative Shift: A Multi-Level Analysis of MMP-13 and TGF-β1.Medicina (Kaunas, Lithuania) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vincent AvecillaRobert Stempel College of Public Health & Social Work, Florida International University, Miami, FL 33199, USA.ORCID 0000-0002-8186-2707

Mayur DokeDiabetes Research Institute, University of Miami, Miami, FL 33136, USA.ORCID 0000-0002-7761-1251

Sandeep AppunniDepartment of Biochemistry, Government Medical College, Kozhikode 673008, Kerala, India.

Muni RubensBaptist Health South Florida, Miami Gardens, FL 33176, USA.ORCID 0000-0003-1812-9753

Venkataraghavan RamamoorthyBaptist Health South Florida, Miami Gardens, FL 33176, USA.ORCID 0000-0002-2448-6733

Jayanta Kumar DasDepartment of Health and Natural Sciences, Florida Memorial University, Miami Gardens, FL 33054, USA.ORCID 0000-0002-2840-1645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular diseases, such as hypertension, atherosclerosis, cerebrovascular, and peripheral arterial diseases, present major clinical and public health challenges, largely due to their common underlying process: vascular remodeling. This process involves structural alterations in blood vessels, driven by a variety of molecular mechanisms. The inhibitor of DNA-binding/differentiation-3 (

Indexed as

Endocrine DisruptorsInhibitor of Differentiation ProteinsVascular DiseasesVascular RemodelingAnimalsBenzhydryl CompoundsEstrogensHumansNeoplasm ProteinsOxidative StressPhenolsSignal TransductionBenzhydryl CompoundsEndocrine DisruptorsEstrogensID3 protein, humanInhibitor of Differentiation ProteinsNeoplasm ProteinsPhenolsendocrine disruptorsID3transcriptional regulatorvascular remodeling

Identifiers

PMID39846697

DOI10.3390/medsci13010002

PMCPMC11755649

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.